Alnylam Pharmaceuticals, Inc. (ALNY)

357.98 -12.02 (-3.25%) USD  |  NASDAQ  |  Jan 23, 16:00
357.98 0.00 (0.00%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Return on Invested Capital (10y Median)

Return on Invested Capital (10y Median) Chart

View Return on Invested Capital (10y Median) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Invested Capital (10y Median) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Invested Capital (10y Median) Range, Past 5 Years

View Return on Invested Capital (10y Median) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Invested Capital (10y Median) Benchmarks

View Return on Invested Capital (10y Median) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Biogen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade